E. J. Lewis

623 total citations
23 papers, 475 citations indexed

About

E. J. Lewis is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, E. J. Lewis has authored 23 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in E. J. Lewis's work include Phytochemistry and Bioactive Compounds (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Vitamin C and Antioxidants Research (3 papers). E. J. Lewis is often cited by papers focused on Phytochemistry and Bioactive Compounds (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Vitamin C and Antioxidants Research (3 papers). E. J. Lewis collaborates with scholars based in United Kingdom, United States and Uganda. E. J. Lewis's co-authors include Joshua D. Bishop, John Nixon, C. H. Cashin, Helen Quasnichka, Allen J. Bailey, Michael E. J. Billingham, D. Bradshaw, Lucy H. Elliott, Sandra E. Wilkinson and Blaine M. Sutton and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

E. J. Lewis

23 papers receiving 447 citations

Peers

Countries citing papers authored by E. J. Lewis

Since Specialization

Citations

This map shows the geographic impact of E. J. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. J. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. J. Lewis more than expected).

Fields of papers citing papers by E. J. Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. J. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. J. Lewis. The network helps show where E. J. Lewis may publish in the future.

Co-authorship network of co-authors of E. J. Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of E. J. Lewis. A scholar is included among the top collaborators of E. J. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. J. Lewis. E. J. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lung function and health-related quality of life among adult patients following pulmonary TB treatment 2024 ·The International Journal of Tuberculosis and Lung Disease ·(unknown), (unknown), Emmanuel Musisi, (unknown), Ingvar Sanyu, Sylvia Kaswabuli, Patrick Byanyima, E. J. Lewis, (unknown), (unknown), Noah Kiwanuka, Kristina Crothers, William Worodria, J. Lucian Davis, Laurence Huang	4
2	Pneumoproteins are associated with pulmonary function in HIV-infected persons 2019 ·PLoS ONE ·(unknown), Emily Chang, (unknown), (unknown), (unknown), E. J. Lewis, John R. Balmes, Daniela Moïsi, Michael M. Lederman, Kristine A. Madsen, Prescott G. Woodruff, Peter W. Hunt, Laurence Huang, (unknown)	8
3	Fundamental subchondral bone changes in spontaneous knee osteoarthritis 2004 ·The International Journal of Biochemistry & Cell Biology ·(unknown), Helen Quasnichka, (unknown), E. J. Lewis, Michael E. J. Billingham, Allen J. Bailey	82
4	Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus 2000 ·Antiviral Research ·E. J. Lewis, Sudhir Agrawal, (unknown), (unknown), (unknown), Scott Cuthill, Paul J. Dunford, Anjalie Field, John Francis, (unknown), (unknown), (unknown), (unknown), John W. Kreider, John Mills, (unknown), Noel A. Roberts, Peter Roberts, David E. Szymkowski	20
5	A simple inflammation model that distinguishes between the actions of anti-inflammatory and anti-rheumatic drugs 1998 ·Inflammation Research ·E. J. Lewis, Joshua D. Bishop, S Aspinall	20
6	Targets for Drug Design 1998 ·Neera Borkakoti, F.K. Winkler, D. H. Williams, (unknown), K M K Bottomley, D. Bradshaw, (unknown), (unknown), Graham Lawton, E. J. Lewis, (unknown), John Nixon	1
7	Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo 1997 ·British Journal of Pharmacology ·E. J. Lewis, Joshua D. Bishop, K M K Bottomley, D. Bradshaw, Michael Brewster, Michael J. Broadhurst, Paul A. Brown, (unknown), Lucy H. Elliott, (unknown), William H. Johnson, John Nixon, Felicity R. A. J. Rose, Blaine M. Sutton, Kevin L. Wilson	100
8	Identification of an antisense oligonucleotide with in vivo activity against human papillomavirus. 2. Efficacy against benign human genital condyloma in a mouse xenograft model 1997 ·Antiviral Research ·E. J. Lewis, David E. Szymkowski, (unknown), John W. Kreider, Peter Roberts, (unknown), (unknown), Robert E. Kilkuskie, John Mills	1
9	A novel in vivo model for the study of cartilage degradation 1993 ·Journal of Pharmacological and Toxicological Methods ·Joshua D. Bishop, (unknown), E. J. Lewis	12
10	Protein kinase C inhibitors 1993 ·Drugs of the Future ·William J. Harris, Christopher H. Hill, E. J. Lewis, John Nixon, Sandra E. Wilkinson	18
11	In vivo changes in plasma acute phase protein levels in the rat induced by slow release of IL‐1, IL‐6 and TNF 1992 ·Mediators of Inflammation ·E. J. Lewis, A. D. Sedgwick, (unknown)	11
12	The design and biological properties of potent and selective inhibitors of protein kinase C 1992 ·Biochemical Society Transactions ·John Nixon, Joshua D. Bishop, D. Bradshaw, Peter D. Davis, Christopher H. Hill, Lucy H. Elliott, (unknown), Geoffrey Lawton, E. J. Lewis, (unknown), D. Westmacott, J. Wadsworth, Sandra E. Wilkinson	64
13	Molecular basis of new approaches to the therapy of rheumatoid arthritis 1991 ·Molecular Aspects of Medicine ·D. Westmacott, D. Bradshaw, (unknown), E. J. Lewis, Edward J. Murray, John Nixon, A. D. Sedgwick	4
14	Oral anti-inflammatory activity of a potent, selective, protein kinase C inhibitor 1991 ·International Journal of Immunopharmacology ·D. Bradshaw, (unknown), E. J. Lewis, Joshua D. Bishop, (unknown), J Nixon, Sandra E. Wilkinson, Lucy H. Elliott, D. Westmacott, J. Wadsworth, (unknown), Thomas Griffiths, A. D. Sedgwick, Peter D. Davis, Christopher H. Hill, Geoffrey Lawton	1
15	Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·David P. Bloxham, D. Bradshaw, C. H. Cashin, (unknown), E. J. Lewis, D. Westmacott, Christopher R. Self	6
16	The effect of retinoids on the skin reaction and swelling seen 7 days after adjuvant injection in the rat paw 1990 ·Inflammation Research ·C. H. Cashin, E. J. Lewis	3
17	Automated quantification of rat plasma acute phase reactants in experimental inflammation 1989 ·Journal of Pharmacological Methods ·E. J. Lewis, Joshua D. Bishop, C. H. Cashin	27
18	Effect of nutritional iron deficiency on acute and chronic inflammation. 1987 ·Annals of the Rheumatic Diseases ·Fiona Andrews, Christopher J. Morris, E. J. Lewis, David R. Blake	32
19	THE DEVELOPMENT OF SCREENING TESTS FOR D-PENICILLAMINE-LIKE ANTIRHEUMATIC ACTIVITY BASED ON IN VIVO INTERACTIONS WITH COPPER 1985 ·Lara D. Veeken ·C. H. Cashin, E. J. Lewis, (unknown)	5
20	Evaluation of hypervitaminosis A in the rat by measurement of tibial bone breaking strain 1984 ·Journal of Pharmacological Methods ·C. H. Cashin, E. J. Lewis	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact